Article Information
PubMed
Print ISSN
Online ISSN
History
- Received May 16, 2003
- Accepted October 24, 2003
- Published online January 27, 2004.
Article Versions
- Earlier version (November 10, 2003 - 15:24).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- S. M. Rawls,
- R. J. Tallarida,
- A. M. Gray,
- Ellen B. Geller and
- Martin W. Adler
- Department of Pharmaceutical Sciences (S.M.R.) and Department of Pharmacology (R.J.T., E.B.G., M.W.A.), Temple University School of Medicine, Philadelphia, Pennsylvania; and GlaxoSmithKline, Inc. (A.M.G.), Research Triangle Park, North Carolina
- Address correspondence to:
Dr. Scott M. Rawls, Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140. E-mail: smrawls28{at}hotmail.com
Statistics from Altmetric.com
Article usage
In this issue
l-NAME (Nω-Nitro-l-Arginine Methyl Ester), a Nitric-Oxide Synthase Inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a Cannabinoid Agonist, Interact to Evoke Synergistic Hypothermia
